RBM35B Activators

The chemical class known as RBM35B Activators consists of various compounds that indirectly enhance the activity of RBM35B, a key RNA-binding protein involved in alternative splicing regulation. These activators include Sodium Butyrate, which alters chromatin structure, promoting the transcription of genes related to splicing regulation. Curcumin influences the Wnt/β-catenin pathway, affecting splicing patterns. Resveratrol enhances RBM35B via sirtuin enzymes and splicing-related pathways. Quercetin influences kinase pathways tied to alternative splicing. Dexamethasone impacts RBM35B through stress and inflammation responses. EGCG modulates RNA splicing signaling pathways.

SB-431542 affects the TGF-β pathway linked to splicing. Staurosporine targets cellular kinases related to splicing regulation. Sodium Arsenite modulates stress responses impacting splicing. Trichostatin A alters histone deacetylases and chromatin structure, affecting splicing events. Wortmannin influences RNA splicing through cellular signaling pathways. Actinomycin D impacts RNA polymerase activity, leading to changes in splicing patterns. These compounds indirectly activate RBM35B, contributing to precise control over alternative splicing.